FMBH Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
FMBH is not a strong buy right now for a beginner long-term investor with $50,000-$100,000. The stock looks technically constructive, but the upside appears fairly limited near current levels and the options/flow data show a heavy bearish lean. Since the user is impatient and wants a direct call, my view is to hold off rather than buy at this price.
Price is 46.24, essentially flat on the day, but the trend remains bullish: SMA_5 is above SMA_20 and SMA_200, and MACD histogram is positive and expanding, which supports near-term upward momentum. RSI_6 at 76.283 suggests the stock is already extended rather than offering an attractive fresh entry. Key levels: pivot 44.772, resistance 46.077 and 46.882, support 43.467 and 42.662. The stock is trading just above the first resistance zone, so near-term upside may be capped unless it breaks higher with conviction. The modeled trend also suggests modest near-term gains, not a compelling long-term entry from current price.
Recent analyst target increases are constructive. DA Davidson, Keefe Bruyette, Raymond James, and Piper Sandler all raised price targets, citing solid Q1 results, organic balance sheet growth, net interest income growth, fee income growth, strong loan growth, NIM expansion, disciplined expenses, and successful integration of Two Rivers Financial Group. The broader technical trend is also positive, with bullish moving averages and expanding MACD.
No news in the recent week means no fresh catalyst is driving the stock today. Hedge funds are reported as selling aggressively over the last quarter, and insiders are neutral. Options positioning is heavily skewed toward puts, which is a negative sentiment signal. The stock is also trading close to resistance and appears somewhat extended after the recent run.
Latest quarter season: Q1. The company’s latest quarter was described by analysts as solid, with organic balance sheet growth, strong net interest income, fee income growth, strong loan growth, NIM expansion, and disciplined expense control. Analysts also noted a seamless deal close with Two Rivers Financial Group. The available data does not include the full financial statements, but the growth commentary points to stable fundamental momentum rather than a breakout growth story.
Wall Street sentiment is mixed to moderately positive. Ratings include Neutral/Market Perform from DA Davidson and Keefe Bruyette, Outperform from Raymond James, and Overweight from Piper Sandler. Price targets were raised to $47, $48, $48, and $55, respectively. The pros view is that earnings quality, NIM expansion, fee growth, and cost discipline support higher EPS and valuation convergence. The cons view is that despite solid fundamentals, some analysts still keep neutral ratings, implying limited near-term re-rating room. No recent politician or congress trading activity was reported.
